NMDA-IN-2
HT1042
2-Methylsuccinic acid
GSK3368715
GSK9311 hydrochloride
CBP/p300-IN-2
Tetrahydrouridine dihydrate
YCN47284
2',3'-Bis(O-t-butyldimethylsilyl)-4',5'-Didehydro-5'-deoxyuridine
SNS-314
CAY10722
FIIN-4
NMDA receptor antagonist 5
DL-Glyceraldehyde 3-phosphate
Span-85
3,4-(Methylenedioxy)cinnamic acid
BPP
NB-598
Manzamine A
Ned-K
FK 866 hydrochloride
Galactosylcerebrosides(hydroxy)
DMT1 blocker 2
AZ-PFKFB3-67 quarterhydrate
Mebeverine acid D5
7-Hydroxydichloromethotrexate
Splenopentin diacetate
Thymoctonan
Antipain
Nelotanserin
TMP778
RORγt Inverse agonist 10
p38 MAP Kinase Inhibitor IV
Burnettramic Acid A
S-Acetyl-L-glutathione
4'-Hydroxy-3',5,5',6,7,8-hexamethoxyflavone
5,7-Dihydroxy 3,3',4',5',6,8-hexamethoxyflavone
Milfasartan
Deacetylforskolin
Pyrimethanil
Methasulfocarb
Aranidipine
MitoPBN
cis-22a
Cefamandole nafate
MRTX-EX185
K67
Bauerenol
Mitiperstat
UK 357903
Substance P Receptor Antagonist 1
Fenspiride
Naproxen etemesil
Autotaxin-IN-1
MCA17-1
P-113 acetate
Dibromoacetaldehyde
Lawesson's reagent
Sodium carbonate
2,4,6-Triiodophenol
